Lance Alan Sloan

Statistics

Publications

Citations

362

H-Index

Active since

2012

Affiliations

Lankenau Institute for Medical Research(Current)

Lance Alan Sloan is an author at Lankenau Institute for Medical Research specializing in clinical pharmacology, diabetes mellitus, and pharmacotherapy.

ORCID

Publications per year

2012–2025

Publications

Long-Term Efficacy and Safety of Linagliptin in Patients With Type 2 Diabetes and Severe Renal Impairment

Janet B. McGill, Lance Alan Sloan, Jennifer Newman et al. · Diabetes Care · 2012 · 206 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Efficacy and Safety of Sitagliptin in Patients With Type 2 Diabetes and ESRD Receiving Dialysis: A 54-Week Randomized Trial

Juan Camilo Arjona Ferreira, Dalila B. Corry, Carl Erik Mogensen et al. · American Journal of Kidney Diseases · 2013 · 129 citations

Medicine, Nephrology, Pharmacotherapy +11

Inadequately Controlled Type 2 Diabetes and Hypercortisolism: Improved Glycemia With Mifepristone Treatment

Ralph A. DeFronzo, Vivian Fonseca, Vanita R. Aroda et al. · Diabetes Care · 2025 · 16 citations · Full text

Medicine, Endocrinology, Pharmacology +14

A study on pharmacokinetics, pharmacodynamics and safety of lixisenatide in children and adolescents with type 2 diabetes

Margarita Barrientos‐Pérez, Daniel S. Hsia, Lance Alan Sloan et al. · Pediatric Diabetes · 2022 · 11 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

1–4 of 4